Colgate-Palmolive weighs $1B+ exit from Softsoap, Irish Spring, Speed Stick

Colgate-Palmolive is exploring a sale of three household personal care brands, Softsoap, Irish Spring, and Speed Stick, and has brought in Goldman Sachs to advise on the potential divestiture. The deal could fetch more than $1 billion, according to a report from Quartz, making it a meaningful portfolio shift for one of the world's largest consumer goods companies. The exploration is early, and no deal is guaranteed, but the involvement of a top investment bank suggests the company is serious about testing buyer appetite.

These brands are far from obscure. Softsoap is a staple in liquid hand soap, Irish Spring has been a shower mainstay for decades, and Speed Stick is a familiar name in deodorant. Yet they sit outside Colgate-Palmolive's core oral care franchise, which includes toothpaste and toothbrushes and has long been the company's profit engine. For executives watching from the sidelines, this is a reminder that even iconic brands can be put on the block when they no longer fit the strategic narrative. The question is not whether these products work, but whether they work hard enough for Colgate's growth goals.

Consumer goods giants routinely prune their portfolios to concentrate resources on categories with higher margins, faster growth, or stronger competitive positions. Colgate's oral care business is the clear priority, and shedding personal care lines could free up capital and management attention for innovation, marketing, and acquisitions in that core area. The move also reflects a broader industry trend: packaged food and personal care companies have been under pressure from private labels, digital-native challengers, and shifting consumer preferences, which has pushed leadership teams to make tough choices about what to keep and what to sell.

A buyer for these brands would be getting more than just product names. Softsoap, Irish Spring, and Speed Stick have deep distribution in North American retail, decades of brand recognition, and loyal customer bases. A private equity firm could see an opportunity to cut costs, refresh marketing, or expand into new channels. Another consumer goods company might want to bolt them onto an existing personal care portfolio and squeeze out synergies. The $1 billion-plus price tag suggests these assets still carry substantial value, even if they are no longer core to Colgate's future.

The regulatory picture is unlikely to be a major hurdle. None of these brands holds a dominant position in its category, so antitrust scrutiny would probably be limited. Buyers will still need to work through supply chain contracts, manufacturing agreements, and brand licensing details, but those are standard issues in any divestiture. For Colgate, the bigger benefit may be simplicity. A leaner portfolio is easier to manage, easier to explain to investors, and easier to align around a single strategic vision.

This exploration also carries a signal for the broader consumer goods sector. When a company of Colgate's scale tests the market for legacy brands, it sets a benchmark for how those assets are valued. If the sale closes at or above the reported $1 billion figure, it could encourage other companies to review their own portfolios for brands that might be worth more to someone else. If it falls through, it would show that even well-known names face a tough market for buyers.

For peers in similar roles, the lesson is to act before pressure builds. Colgate is not in distress; it is making a proactive choice to reshape its business. That is the kind of move that can create value for shareholders and sharpen competitive focus. Waiting until a brand becomes a drag on earnings often means selling from a position of weakness. The companies that thrive in this environment are the ones that regularly ask whether every asset in the portfolio is earning its keep.

The exploration is still early, and Colgate could decide to keep the brands if bids come in too low. But the fact that Goldman Sachs is involved means the company is likely to get a clear read on what the market will pay. For executives, the takeaway is straightforward: test the market for assets that no longer fit your core strategy, and use the process to inform your own valuation of the portfolio. Whether or not this deal closes, Colgate has already made a statement about where it wants to focus.